Pfizer (PFE) stock and Arvinas (ARVN) stock are in focus as the FDA approves the companies' breast cancer drug, Veppanu. Read ...
By Padmanabhan Ananthan May 1 (Reuters) - The U.S. Food and Drug Administration on Friday approved Pfizer and Arvinas' breast ...
VEPPANU™ is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader – – Approval received in ...
Pfizer shows steady pharmaceutical progress with oncology growth and drug protection strength, shaping healthcare dynamics ...
Blue-chip stocks are shares of large, well-established, financially stable companies with a consistent and reliable ...
The U.S. Food and Drug Administration has appointed Katherine Szarama as the acting director of its Center for Biologics Evaluation and Research, which regulates vaccines and biologic drugs, Politico ...
24/7 Wall St. on MSN
Just five dividend stocks transform $500,000 into $3,100 a month in retirement income
Quick Read A $500,000 portfolio split equally across Realty Income (O), Ares Capital (ARCC), Enterprise Products Partners ...
Arvinas and Pfizer are the first to take a PROteolysis TArgeting Chimera (PROTAC) therapy across the FDA finish line, opening ...
Arvinas and Pfizer received approval from the Food and Drug Administration for Veppanu, the companies' jointly developed advanced breast cancer treatment. Arvinas said Friday the FDA approved the drug ...
AutoNation, Inc.(NYSE: AN) today reported first quarter 2026 revenue of $6.6 billion, a decrease of 2% compared to the same period a year ago. For the quarter, EPS was $5.85, compared to $4.45 a year ...
Next week’s stock market catalyst calendar: earnings, Fed SLOOS/fedspeak, IPOs, dividends and macro data that could move ...
Rockwell Automation, Inc. (NYSE:ROK), the world’s largest company dedicated to industrial automation and digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results